
Opthea Appoints Hamish George As CFO

Opthea Ltd. has appointed Hamish George as Chief Financial Officer, effective immediately. Additionally, Stephanie Vipond from Bio101 will take over as Joint Company Secretary, replacing Karen Adams. Both will manage communications between the company and ASX. Shares are currently trading at $3.41 on the Nasdaq.
Opthea Ltd. (OPT.AX,OPT), a clinical-stage biopharmaceutical company, Monday announced the appointment of Hamish George as Chief Financial Officer, effective today.
The company also stated that Stephanie Vipond of Bio101 will assume the role of Joint Company Secretary in place of Karen Adams, effective today.
Together, George and Vipond are responsible for communication between the Company and ASX.
In the pre-market activity, shares are trading at $3.41 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News

